9 Myalgic Encephalomyelitis Clinical Trials in The Bronx, NY (2026)

Q: How do I join a clinical trial in The Bronx?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in The Bronx

NCT06545331Recruiting

Study of XB010 in Subjects With Solid Tumors

This is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with lo...

The Bronx, NYPHASE1396 participantsExelixis

View Study Details

NCT05422911Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Veterans with mCRPC. In the real-world that is the VHA, the investigators have succe...

The Bronx, NYPHASE2192 participantsSun Pharmaceutical Industries Limited

View Study Details

NCT06962800Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glome...

The Bronx, NYPHASE3180 participantsBiogen

View Study Details

NCT06240728Recruiting

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

NPX887 is a human, antagonistic immunoglobulin G1 (IgG1) monoclonal antibody targeting B7-H7 (HHLA2) that may potentiate an anti-tumor immune response. The goal of this first-in-human study is to lear...

The Bronx, NYPHASE1144 participantsNextPoint Therapeutics, Inc.

View Study Details

NCT06925776Recruiting

Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization

The goal of this clinical trial is to learn if this intervention (the CHOOSE Home intervention) is feasible and may lead to more home dialysis usage in a high-risk patient population. The main questio...

The Bronx, NYNA106 participantsMontefiore Medical Center

View Study Details

NCT03540758Recruiting

Regulation of Endogenous Glucose Production by Central KATP Channels

Type 2 diabetes (T2D) affects the ability of the body to process glucose (sugar). Under fasting conditions, the liver is able to make sugar to maintain glucose levels in an important process called en...

The Bronx, NYPHASE2100 participantsAlbert Einstein College of Medicine

View Study Details

NCT06196203Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of AK117 or placebo, combined with azacitidine in patients with newly diagnosed hig...

The Bronx, NYPHASE290 participantsAkeso

View Study Details

NCT05172245Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients ...

The Bronx, NYPHASE146 participantsNational Cancer Institute (NCI)

View Study Details

NCT06654037Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

This phase I trial tests the safety, side effects, and best dose of abemaciclib in combination with 5-fluorouracil and how well it works in treating patients with colorectal cancer that has spread fro...

The Bronx, NYPHASE139 participantsNational Cancer Institute (NCI)

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in The Bronx

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 9 myalgic encephalomyelitis clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 1,293 participants. Research is being sponsored by Exelixis, Sun Pharmaceutical Industries Limited, Biogen and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in The Bronx — FAQ

Are there myalgic encephalomyelitis clinical trials in The Bronx?

Yes, there are 9 myalgic encephalomyelitis clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 9 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated October 18, 2026 from ClinicalTrials.gov